Amundi’s Myovant Sciences Ltd. MYOV Stock Holding History

Amundi’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,919	Closed	-$98K	–	2015
2022 Q3	$98K	Buy	+3,919	New	+$62.6K	﹤0.01%	1557

Other funds holding MYOV

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Amundi's MYOV Position: Q4 2022 in Review

Amundi sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 3,919 shares — an estimated $98K sold.

Amundi first reported a position in MYOV in Q3 2022 and held it in 1 quarter. The position peaked at $98K in Q3 2022. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

Amundi reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
Amundi sold 3,919 Myovant Sciences Ltd. shares in Q4 2022, an estimated $98K.
Amundi first reported a position in Myovant Sciences Ltd. in Q3 2022 and held it in 1 quarter.
Amundi's Myovant Sciences Ltd. position peaked at $98K in Q3 2022.
118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Amundi's 13F filing for Q4 2022, filed 14 Feb 2023.